WRWolfgang Retz

Wolfgang Retz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wolfgang Retz has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: Interaction with adverse childhood environment

    by Wolfgang Retz, Christine M. Freitag, Petra Retz-Junginger, Denise Wenzler, Marc Schneider, Christian Kissling, Johannes Thome, Michael Rösler


  • Suchtmittelgebrauch bei jungen erwachsenen Straftätern mit und ohne Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS)

    by W. Retz, P. Retz-Junginger, M. Schneider, H. Scherk, G. Hengesch, M. Rösler

    Soziale Anpassungsprobleme werden sowohl bei Patienten mit Suchterkrankungen als auch bei Vorliegen einer Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) häufig angetroffen. Es wurden daher in einer Querschnittsuntersuchung 129 Häftlinge einer Jugendstrafanstalt systematisch auf das Vorliegen einer ADHS, Drogenabhängigkeit und -missbrauch sowie bezüglich ihres Alkoholkonsums untersucht. 64,3 % der Probanden wiesen einen risikohaften Alkoholkonsum auf. Bei 67,4 % wurde ein Drogenmissbrauch oder eine Abhängigkeit von Drogen festgestellt. 28,8 % der drogenabhängigen Straftäter erfüllten die diagnostischen Kriterien einer ADHS vom Mischtyp gemäß DSM-IV. Bei weiteren 52,1 % der drogenabhängigen Probanden lag eine ADHS Symptomatik in der Kindheit vor. In dieser Gruppe fand sich eine höhere psychosoziale Belastung. Bei drogenabhängigen Straftätern ohne ADHS wurde im Vergleich zu Straftätern mit ADHS häufiger eine Opiatabhängigkeit diagnostiziert. Die Probandengruppe mit ADHS erwies sich sowohl im Bereich externalisierender als auch internalisierender Psychopathologie als besonders auffällig. Im Persönlichkeitsprofil zeigten diese Probanden die höchsten Neurotizismuswerte und die niedrigsten Werte auf der Skala Gewissenhaftigkeit. Die hohe Prävalenz von Drogenabhängigkeit und -missbrauch und die hohe Komorbidität mit ADHS lassen auch aus kriminalpräventiven Gesichtspunkten suchtmedizinische Behandlungsangebote für junge Straftäter unter Berücksichtigung einer ADHS notwendig erscheinen. Prospective studies of children with ADHD have shown a high level of substance use disorder comorbidity, particularly when associated with social maladaptation and antisocial behavior. Conversely, studies of drug abusing participants and delinquents revealed a high prevalence of ADHD comorbidity. In this study 129 young male prison inmates were systematically examined for ADHD and substance use disorders. 64,3 % showed harmful alcohol consumption. 67,4 % fulfilled DSM-IV criteria for any drug abuse or dependence. 28,8 % of these participants were diagnosed with ADHD, combined type, other 52,1 % showed ADHD residual type. Opioid dependence was more common in delinquents without ADHD. Addicted delinquents with ADHD showed worse social environment and a higher degree of psychopathology, including externalizing and internalizing behavior, compared to addicted delinquents without ADHD. Neuroticism and conscientiousness ratings of the addicted ADHD group, but not of those without ADHD, differed from non-addicted delinquents. The results underline the need of adequate therapeutic programs for addicted young prison inmates considering ADHD comorbidity, which is associated with additional psychopathology and social problems.


  • Wirksamkeit und Sicherheit von Rivastigmin bei Patienten mit Demenz unter Praxisbedingungen

    by F. Tracik, M. Rösler, W. Retz

    Das Ziel dieser offenen, prospektiven Beobachtungsstudie war es, den klinischen Verlauf von Patienten mit Demenz unter der Therapie mit Rivastigmin, einem Azetylcholinund Butyrylcholinesterasehemmstoff, unter Praxisbedingungen zu untersuchen. 867 Ärzte in Arztpraxen, Ambulanzen und Memory-Kliniken rekrutierten 1 214 Demenzpatienten, von denen 75% leicht bis mittelgradig (Mini-Mental-State-Test ≥ 10) und 25% schwergradig ausgeprägte Symptome aufwiesen. Die Patienten erhielten Rivastigminlösung peroral in einer durchschnittlichen Tagesdosierung von 6,7 mg über4 Monate. Unter Rivastigmin besserten sich die Patienten in allen untersuchten Symptombereichen (Gedächtnis-, Sprach-, Orientierungs-, Verhaltensund Alltagskompentenzstörungen) signifikant (p < 0,05). Bei Patienten mit schwergradiger Demenz war der therapeutische Effekt von Rivastigmin am stärksten ausgeprägt. Die Verträglichkeit von Rivastigmin wurde von 93,2% der behandelnden Ärzte als gut oder sehr gut beurteilt. Rivastigmin zeigte bei Patienten mit leicht bis schwergradiger Demenz unter Praxisbedingungen eine klinisch relevante Wirksamkeit und gute Verträglichkeit. The aim of the present observational open study was to investigate prospectively the clinical effects of rivastigmine, an inhibitor of acetylcholinesterase as well as butyrylcholinesterase, on the course of patients with dementia under “real life” practice conditions. 867 physicians in primary care settings and memory clinics included 1 214 patients with dementia of whom 75% had mild to moderate (Mini Mental State Examination ≥ 10) and 25% severe symptoms. Rivastigmine solution was administered orally at an average daily dose of 6.7 mg over4 months. All investigated symptoms (disturbances of memory, speech, orientation, behaviour and capability of daily living) significantly improved during treatment with rivastigmine (p< 0.05). The therapeutic effect of rivastigmine was most pronounced in patients with severe dementia. 93.2% of the treating physicians judged the tolerability of rivastigmine to be good or very good. Rivastigmine revealed clinical relevant efficacy and was tolerated well by patients with mild to severe dementia.

  • Psychometric and psychopathological characterization of young male prison inmates with and without attention deficit/hyperactivity disorder

    by W. Retz, P. Retz-Junginger, G. Hengesch, M. Schneider, J. Thome, F.-G. Pajonk, A. Salahi-Disfan, O. Rees, P. H. Wender, M. Rösler

    There is considerable evidence that attention deficit/hyperactivity disorder (ADHD) is associated with conduct problems, social maladaptation and delinquent behavior. The “Ottweiler Study” was performed to elaborate the prevalence of ADHD and comorbid disorders in 129 young adult detainees of the juvenile prison of Ottweiler (Germany) according to DSM-IV and ICD-10 criteria. Here we report psychopathological characteristics of 28 inmates, who fulfilled the diagnostic criteria for persisting ADHD, and 37 individuals with neither a history nor current ADHD symptoms. Childhood ADHD symptoms but no current ADHD were present in 64 individuals. The Wender–Reimherr Interview (WRI) based on the Utah criteria for adult ADHD, the NEO–five factor personality inventory (NEO–FFI) and the youth self report/young adult self report (YSR/YASR) according to Achenbach were used for the assessment of psychopathology and the description of behavioral problems. Regarding WRI and YSR/YASR we found a significant increase of emotional and internalizing problems in the ADHD group compared to delinquents without ADHD or ADHD history. ADHD delinquents scored higher on the personality dimension neuroticism, and showed lower scores on the dimensions agreeableness and consciousness. Using discriminant analysis, high scores on the WRI subscales disorganization and attention difficulties and NEO–FFI neuroticism were the best predictors of ADHD diagnosis. The results support prior findings of high ADHD prevalence in prison inmates and suggest that emotional and internalizing abnormalities are prominent problems in this population. Further studies are needed to elucidate the role of ADHD as an independent factor for life–persistent criminality, since specific treatment may help to ameliorate the legal prognosis.


  • Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology

    by Wolfgang Retz, Petra Retz‐Junginger, Tillmann Supprian, Johannes Thome, Michael Rösler

    There is evidence that disturbances in central serotonin (5‐HT) function have a role in impulsive aggression, violence, and criminality. A deletion/insertion polymorphism within the 5‐HT transporter (5‐HTT) promoter gene (5‐HTT gene‐linked polymorphic region, 5‐HTTLPR) is thought to be associated with several psychopathological phenotypes related to disturbed impulse control, anxiety and depression. This study examined the association of the 5‐HTTLPR with violent behavior in a sample of 153 male Caucasians referred for a forensic psychiatric examination. We found a significant excess of the short (s) allele and the s/s genotype in patients characterized by recurrent and overt physical violent behavior. This genetic variance explained 5% of the variance of violent behavior. When controlled for the impact of several psychopathologies related to violent behavior, this association was observed in individuals with a history of childhood attention deficit/hyperactivity disorder (ADHD)‐related symptoms, but not presenting with personality disorder or increased impulsiveness. In conclusion, the results (i) suggest an association between serotonergic dysfunction and violent behavior, (ii) provide evidence for an—at least partial—genetic regulation of violent behavior in a subgroup of male offenders, and (iii) suggest a significant role for 5‐HT transporter functionality for violent behavior. Copyright © 2004 John Wiley & Sons, Ltd.